Articles
-
-
Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
-
Urolithin A promotes p62-dependent lysophagy to prevent acute retinal neurodegeneration
-
Fate-mapping and functional dissection reveal perilous influence of type I interferon signaling in mouse brain aging
-
Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS
Aims and scope
Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal dedicated to publishing groundbreaking research in the field of neurodegeneration. Our mission is to foster a deeper understanding of neurodegenerative diseases, including but not limited to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, and macular degeneration, to inform novel diagnosis and effective therapy. We aim to publish innovative studies addressing the complex mechanisms of neurodegenerative disorders at the molecular, cellular, and systems levels, with a strong emphasis on broad impact and scientific rigor.
Collections
Glial and Vascular Contributions to Neurodegenerative Diseases
See Molecular Neurodegeneration's ongoing Collection on Glial and Vascular Contributions to Neurodegenerative Diseases.
ALS: Challenges and New Advances
See Molecular Neurodegeneration's ongoing Collection on ALS: Challenges and New Advances.
News from Alzforum
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 14.9
5-year Journal Impact Factor: 16.7
Source Normalized Impact per Paper (SNIP): 2.566
SCImago Journal Rank (SJR): 5.205Speed 2023
Submission to first editorial decision (median days): 26
Submission to acceptance (median days): 150Usage 2023
Downloads: 1,584,169
Altmetric mentions: 2,567
Contact the Managing Editorial Team
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline